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Abstract 
 
Saliva is a crucial biofluid for oral health and is also of increasing importance as a non-
invasive source of disease biomarkers. Salivary alpha-amylase is an abundant protein in 
saliva, and changes in amylase expression have been previously associated with a variety of 
diseases and conditions. Salivary alpha-amylase is subject to a high diversity of post-
translational modifications, including physiological proteolysis in the oral cavity. Here we 
developed methodology for rapid sample preparation and non-targeted LC-ESI-MS/MS 
analysis of saliva from healthy subjects and observed an extreme diversity of alpha-amylase 
proteolytic isoforms. Our results emphasize the importance of consideration of post-
translational events such as proteolysis in proteomic studies, biomarker discovery and 
validation, particularly in saliva.   
 
Keywords: saliva; alpha-amylase; liquid chromatography; mass spectrometry; proteolysis; 
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1. Introduction 
 
Saliva is an important biofluid in the oral cavity, aiding in physical lubrication, tooth enamel 
mineralisation, protection against infection, wound healing, mastication and taste sensation 
[1, 2]. The components of whole saliva are contributed from various glandular secretions, 
including the parotid, submandibular and sublingual glands, gingival crevicular fluid, 
nasobronchial secretions, blood and plasma leakage from oral wounds, epithelial cells, food 
particles and microorganisms. Due to this high diversity of sources, the composition of whole 
saliva is a complex and variable. Regulation of this variability is crucial for homeostasis of 
the oral cavity and hence in oral health. Alterations in the protein composition of saliva have 
also been associated with diverse diseases, including periodontitis [3], oral cancers [4], and 
autoimmune diseases such as Sjögrens Syndrome [5]. The changes in salivary protein 
composition observed in these states may contribute to the progression of these conditions, 
and may also be of use for identification of biomarkers for disease prognosis or diagnosis [2].  
 
Salivary α-amylase is an abundant protein in saliva, with diverse roles in oral biology. 
Amylase catalyses the hydrolysis of internal α1-4 glucosidic bonds from various glucose 
polymers [6] and as such is an important enzyme in the early stages of carbohydrate 
digestion. Catalytically active salivary amylase has been reported to bind to microorganisms 
and tooth enamel, and as such is perhaps crucial in mediating adherence of pathogens to oral 
surfaces, and allowing microbial growth through provision of glucose from the breakdown of 
dietary glucose polymers [7-10]. Changes in the levels of salivary amylase have been 
reported in many proteomic studies, including implications in periodontitis [3], Sjögrens 
Syndrome [5, 11], sensory perception of bitter tastes [12], and in binding of salivary tannins 
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[13-16]. It has also been reported that α-amylase is subject to a very high level of 
posttranslational modification. The two potential N-glycosylation sites in salivary amylase 
are partially modified [17], and amylase is also subject to a high diversity of various post-
translational modifications including deamidation of asparagine and glutamine residues [18]. 
In particular, protease digestion within the oral cavity results in a very large number of 
proteolytic isoforms of amylase. A previous study performed peptide fingerprint mapping 
with MALDI-TOF-MS of over 140 salivary amylase isoforms separated by 2D SDS-PAGE, 
confirming that this diversity is largely the result of proteolysis [19]. However, the relevance 
of this proteolytic diversity to proteomic analyses and biomarker discovery is unknown. 
 
With the goal of examining the molecular diversity of salivary α-amylase, here we have 
developed and used a rapid and efficient combination of sample preparation and LC-ESI-
MS/MS detection to perform a detailed non-targeted analysis of salivary amylase isoforms 
resulting from physiological proteolysis in the oral cavity. We observe extreme diversity of 
proteolytic isoforms, map the sites of proteolysis and validate the diversity of selected 
proteolysis events in healthy subjects. 
 
2 Materials and Methods 
 
2.1 Saliva collection 
This study was approved by The University of Queensland Medical Ethical Institutional 
Board. All participants gave informed consent before sample collection. All study 
participants were over 18 years of age. Whole resting saliva was collected as described [20, 
21], supplemented with protease inhibitor cocktail and placed immediately on wet ice. 
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2.2. Sample preparation 
Whole saliva samples were diluted directly to 6M guanidinium chloride, 50 mM TrisCl pH 8 
and 10 mM DTT, and incubated at 37oC for 30 min. Cysteines were alkylated by addition of 
acrylamide to 25 mM and incubation at 23oC for 1 hr. Protein was subjected to 
methanol:acetone precipitation, resuspended in 50 mM ammonium acetate and digested with 
trypsin as described [22]. Peptides were desalted using C18 ZipTips (Millipore).  
 
2.3 Mass spectrometry 
Desalted peptides were analyzed by LC-ESI-MS/MS using a Prominence nanoLC system 
(Shimadzu) and TripleTof 5600 mass spectrometer with a Nanospray III interface (ABSciex). 
Peptides were desalted on an Agilent C18 trap (5 µm, 0.3 x 5 mm) at a flow rate of 30 µl/min 
for 3 min, and then separated on a Vydac Everest C18 column (300 Å, 5 µm, 5 mm x 150 
µm) at a flow rate of 1 µl/min. Peptides were separated with a gradient of 10-60% buffer B 
over 30 min, with buffer A (1% acetonitrile and 0.1 % formic acid) and buffer B (80% 
acetonitrile with 0.1% formic acid). Gas and voltage setting were adjusted as required. An 
MS TOF scan from m/z of 350-1800 was performed for 0.5 s followed by information 
dependent acquisition of MS/MS with automated CE selection of the top 20 peptides from 
m/z of 40-1800 for 0.05 s per spectrum.  
 
2.4 Data analysis 
Peptides were identified using an in-house installation of ProteinPilot, searching the UniProt 
database (as of 11th January 2012) with standard settings (Sample type, identification; 
cysteine alkylation, acrylamide; Instrument, TripleTOF 5600; Species, none; ID focus, 
biological modifications; Search effort, Thorough ID). False discovery rate analysis was 
performed for all samples. Peptides identified with greater than 99% confidence were 
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included for further analysis, and MS/MS fragmentation spectra were manually inspected. 
Extracted ion chromatograms were obtained using PeakView 1.1. Protein structural analysis 
was performed using MacPymol.  
 
3 Results and Discussion 
 
3.1 Identification of sites of physiological proteolysis in salivary α-amylase  
We detected sites of physiological protease digestion of salivary α-amylase. We analysed 
trypsin-digested pooled whole saliva from healthy subjects by untargeted LC-ESI-MS/MS 
and identified peptides with ProteinPilot. This resulted in identification of 63 peptides from 
salivary α-amylase with over 99% confidence (Table 1). Remarkably, 2/3rds of these (43 
independent peptides) were semi-tryptic peptides, representing 38 independent sites of 
physiological proteolysis.  
 
3.2 Characteristics of salivary α-amylase proteolysis sites 
To determine patterns behind the physiological proteolysis events we identified, we mapped 
these sites of proteolysis to the sequence of mature salivary α-amylase (Fig. 1A). This 
showed clusters of proteolysis, rather than an even spread of sites throughout the protein 
sequence. Further, we mapped the sites of physiological proteolysis on the 3D crystal 
structure of salivary α-amylase [23] (Fig. 1B,C,D). Again, this showed clustering of sites of 
proteolysis, with almost all proteolysis events mapping to surface exposed portions of the α-
amylase protein. While proteolysis sites generally mapped to the surface of α-amylase, they 
were not evenly distributed over the protein surface. Intriguingly, sites of proteolysis mapped 
to regions of α-amylase previously reported to be not involved in non-catalytic binding of 
glucose polysaccharides [24]. This suggests that binding of saccharide to portions of the 
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surface of α-amylase in saliva in the oral cavity provides physical protection of the 
underlying protein surface, while the remaining exposed α-amylase surface is accessible to 
protease digestion.  
 
3.3 Non-surface exposed salivary α-amylase proteolysis sites 
Although most clusters of physiological proteolysis were on the surface of the mature α-
amylase protein, some sites were not surface exposed. One such cluster of proteolysis sites 
was from M323 to M328 (Table 1, Fig 2). These residues are in the middle section of an α-
helix on the side of the core α-amylase catalytic domain, but covered by the 90 amino acid C-
terminal domain of α-amylase. Several physiological proteolysis sites mapped to this C-
terminal domain, including at F406 and N408, present in a short linker between the core and 
C-terminal domains. This suggests that cleavage at F406 or N408 may release the C-terminal 
domain, expose this side of the core α-amylase domain and allow subsequent proteolysis at 
the M323-M328 cluster.  
 
3.4 Abundance of salivary α-amylase physiological proteolysis events 
The intensity of extracted ion chromatograms corresponding to tryptic and semi-tryptic 
peptides from the M323-M328 proteolysis cluster suggest that the majority of α-amylase is 
not subject to proteolysis at this site, as the semi-tryptic peptides show much lower intensity 
than the non-proteolytic full-length tryptic peptide (Fig. 2). This pattern was also present in 
comparison of the intensity of all tryptic and semi-tryptic peptides, with full tryptic peptides 
being on average ten fold more intense than semi-tryptic peptides (Fig. 3A). This suggests 
that the detected physiological proteolysis sites are individually rare in the overall pool of 
salivary α-amylase proteins. However, given the extreme diversity of potential proteolysis 
sites we identified, it is in fact likely that the majority of α-amylase proteins are subject to 
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physiological proteolysis, in agreement with previous proteomic studies [19]. It is possible 
that initial proteolysis may be rate limiting, and the flexibility engendered by this cleavage 
leads to an increased rate of subsequent proteolysis at nearby or distal sites. It is also 
conceivable that many of the proteolytically processed α-amylase isoforms may still be 
functional. Five disulfide bonds are present in the mature structure of salivary α-amylase 
[23], and as structural disulfide bonds these serve to increase the stability of the mature 
protein. Proteolytic digest of a single surface site would likely increase local flexibility, but 
with the overall protein structure retained. The influence on the glucosidic hydrolysis or 
saccharide binding activities of α-amylase could be variable depending on the site and 
number of proteolysis events in a given α-amylase protein molecule.  
 
3.5 Salivary α-amylase proteolytic diversity 
The previous most detailed study on proteolytic isoforms of salivary α-amylase reported 
approximately 140 isoforms detectable by 2D SDS-PAGE [19]. This previous study used 
MALDI-TOF-MS and peptide mass fingerprinting with predicted full tryptic peptides to map 
the coverage of amylase isoforms. The use of full tryptic peptides limited the resolution at 
which the proteolysis events resulting in isoforms could be mapped to the closest lysine or 
arginine residue. In contrast, our analysis here has mapped the precise sites of proteolysis 
with untargeted LC-ESI-MS/MS detection and database searching, including identification of 
semi-tryptic peptides which precisely map the sites of physiological proteolysis. In general, 
our approach detected that sites of proteolysis were clustered within the α-amylase sequence 
(Table 1, Fig. 1 and 2). This suggests that many of the individual 2D SDS-PAGE gel spots 
identified as salivary α-amylase isoforms [19] actually contain multiple isoforms, differing 
only by a few amino acids. In turn, this implies that the actual physiological proteolytic 
isoform diversity of salivary α-amylase is much greater than these ~140 spots. As the clusters 
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of proteolysis we detected consisted of an average of 3.3 independent precise sites of 
proteolysis, the total number of physiological proteolytic salivary amylase isoforms is likely 
more than triple the number of 2D SDS-PAGE spots, or more than 500 distinct isoforms. The 
presence of any additional rare, low abundant proteolysis sites would further increase the 
diversity of salivary α-amylase isoforms. 
 
3.6 Validation of salivary α-amylase proteolysis 
To gauge the generality of our findings, we validated a selected subset of proteolysis events 
by LC-ESI-MS/MS analysis of individual whole saliva samples from healthy subjects. For 
this we used the proteolysis cluster internal to mature α-amylase, M323-M328 (Fig. 2), and 
determined the intensity of full-length tryptic and semi-tryptic peptides resulting from 
physiological proteolysis as judged by extracted ion chromatograms in these individuals (Fig. 
3B). The same semi-tryptic peptides were detected in all samples, indicating that these 
physiological proteolysis events are common in healthy subjects. Further, the relative 
abundances of each of these tryptic and semi-tryptic peptides showed limited variability 
between individuals. This supports the utility of the rapid LC-ESI-MS/MS analysis we 
performed for semi-quantitative analysis of multiple sites of physiological proteolysis in 
salivary α-amylase. 
 
4 Conclusions 
In conclusion, we have developed and used a rapid and straightforward method for 
untargeted LC-ESI-MS/MS analyses of trypsin-digested proteins from minimally processed 
whole saliva to map the sites of physiological proteolysis of salivary α-amylase. Our results 
emphasize the unusually high extent of modification of this abundant salivary protein, which 
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is of direct relevance to the discovery, validation and use of α-amylase and other proteins as 
disease biomarkers in saliva. 
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Table 1. Tryptic and semi-tryptic peptides from salivary α-amylase. 
Position Sequence Semi-tryptic 
cleavages 
m/z z Δmass 
11-20 TSIVHLFEWR  644.35 2 0.0000 
12-20 SIVHLFEWR T-S@N-term 593.82 2 -0.0005 
13-20 IVHLFEWR S-I@N-term 550.31 2 -0.0009 
21-30 WVDIALECER  652.82 2 -0.0001 
36-56 GFGGVQVSPPNENVAIHNPFR R-P@C-term 1118.57 2 0.0027 
36-61 GFGGVQVSPPNENVAIHNPFRPWWER  997.50 3 0.0010 
43-61 SPPNENVAIHNPFRPWWER V-S@N-term 1174.08 2 1.0011 
44-61 PPNENVAIHNPFRPWWER S-P@N-term 753.71 3 0.0012 
45-61 PNENVAIHNPFRPWWER P-P@N-term 1081.54 2 0.0018 
49-61 VAIHNPFRPWWER N-V@N-term 427.73 4 0.0030 
93-102 IYVDAVINHM M-C@C-term 587.80 2 0.0006 
93-105 IYVDAVINHMCGN N-A@C-term 760.35 2 -0.0028 
93-124 
IYVDAVINHMCGNAVSAGTSSTCGSYF
NPGSR  1140.85 3 0.0039 
103-124 CGNAVSAGTSSTCGSYFNPGSR M-C@N-term 1132.99 2 -0.0033 
106-124 AVSAGTSSTCGSYFNPGSR N-A@N-term 960.43 2 -0.0021 
125-131 DFPAVPY Y-S@C-term 404.70 2 0.0008 
125-140 DFPAVPYSGWDFNDGK  907.91 2 0.0020 
143-158 TGSGDIENYNDATQVR  870.39 2 -0.0007 
162-176 LSGLLDLALGKDYVR  544.98 3 -0.0002 
163-176 SGLLDLALGKDYVR L-S@N-term 760.42 2 -0.0060 
164-176 GLLDLALGKDYVR S-G@N-term 716.91 2 -0.0017 
179-195 IAEYMNHLIDIGVAGFR  640.33 3 -0.0006 
180-195 AEYMNHLIDIGVAGFR I-A@N-term 903.45 2 0.0021 
181-195 EYMNHLIDIGVAGFR A-E@N-term 867.93 2 -0.0016 
182-195 YMNHLIDIGVAGFR E-Y@N-term 803.41 2 -0.0021 
183-195 MNHLIDIGVAGFR Y-M@N-term 481.59 3 0.0015 
185-195 HLIDIGVAGFR N-H@N-term 399.90 3 0.0012 
201-208 HMWPGDIK  492.24 2 -0.0021 
214-227 LHNLNSNWFPEGSK K-P@C-term 821.90 2 0.0009 
214-229 LHNLNSNWFPEGSKPF F-I@C-term 629.65 3 0.0031 
214-234 LHNLNSNWFPEGSKPFIYQEV V-I@C-term 840.42 3 -0.0009 
214-243 
LHNLNSNWFPEGSKPFIYQEVIDLGGEP
IK  1147.92 3 0.0014 
219-243 SNWFPEGSKPFIYQEVIDLGGEPIK N-S@N-term 950.82 3 0.0032 
223-243 PEGSKPFIYQEVIDLGGEPIK F-P@N-term 1158.61 2 -0.0054 
228-243 PFIYQEVIDLGGEPIK K-P@N-term 909.49 2 0.0010 
230-243 IYQEVIDLGGEPIK F-I@N-term 787.43 2 0.0005 
244-252 SSDYFGNGR  501.72 2 -0.0011 
279-291 NWGEGWGFMPSDR  769.83 2 -0.0010 
292-303 ALVFVDNHDNQR  714.35 2 -0.0078 
294-303 VFVDNHDNQR L-V@N-term 622.29 2 -0.0012 
304-315 GHGAGGASILTF F-W@C-term 544.28 2 0.0012 
304-319 GHGAGGASILTFWDAR  808.40 2 0.0006 
323-333 MAVGFMLAHPY Y-G@C-term 618.80 2 -0.0002 
323-335 MAVGFMLAHPYGF F-T@C-term 720.84 2 -0.0029 
323-337 MAVGFMLAHPYGFTR  849.42 2 -0.0003 
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324-337 AVGFMLAHPYGFTR M-A@N-term 783.90 2 -0.0008 
325-337 VGFMLAHPYGFTR A-V@N-term 748.38 2 0.0000 
326-337 GFMLAHPYGFTR V-G@N-term 698.85 2 0.0000 
327-337 FMLAHPYGFTR G-F@N-term 670.33 2 -0.0032 
328-337 MLAHPYGFTR F-M@N-term 596.80 2 -0.0032 
347-368 YFENGKDVNDWVGPPNDNGVTK  1233.07 2 -0.0004 
353-368 DVNDWVGPPNDNGVTK  576.27 3 -0.0038 
369-387 EVTINPDTTCGNDWVCEHR  1166.01 2 -0.0014 
373-387 NPDTTCGNDWVCEHR I-N@N-term 944.89 2 -0.0010 
399-421 NVVDGQPFTNWYDNGSNQVAFGR  862.40 3 -0.0032 
407-421 TNWYDNGSNQVAFGR F-T@N-term 865.38 2 0.0009 
409-421 WYDN*GSNQVAFGR N-W@N-term 757.35 2 0.0020 
475-495 AHFSISNSAEDPFIAIHAESK  757.71 3 -0.0002 
478-495 SISNSAEDPFIAIHAESK F-S@N-term 958.47 2 -0.0028 
482-495 SAEDPFIAIHAESK N-S@N-term 505.59 3 -0.0023 
483-495 AEDPFIAIHAESK S-A@N-term 714.36 2 -0.0013 
484-495 EDPFIAIHAESK A-E@N-term 678.84 2 0.0018 
485-495 DPFIAIHAESK E-D@N-term 614.32 2 0.0006 
* Deamidated Asn. All Cys are alkylated. 
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Figure Legends 
 
Figure 1. Sites of physiologic proteolysis in salivary α-amylase. (A) Sequence of mature 
salivary α-amylase. Sequence coverage by tryptic and semi-tryptic peptides (Table 1) is 
shown in bold. Arrows show detected sites of physiologic proteolysis as determined by the 
non-tryptic termini of semi-tryptic peptides. (B), (C), (D) Rotated views of surface 
representations of the crystal structure of salivary α-amylase [23]. Sites of previously 
reported non-catalytic saccharide binding [24] are coloured blue. Selected sites of 
physiological proteolysis (Table 1) are labelled and coloured wheat. Active site residues are 
coloured red. 
 
Figure 2. Physiological proteolysis of an internal section of salivary α–amylase. (A) Cartoon 
of mature salivary α–amylase [23]. Sites of physiological proteolysis (Table 1) are labelled 
and coloured wheat. MS/MS spectra identifying full-length tryptic (B, C) and semi-tryptic 
(D, E, F, G, H) peptides from this region, with corresponding extracted ion chromatograms as 
inserts (MS/MS spectra and extracted ion chromatograms from ions with m/z of: (B) 757.35 
2+, (C) 849.42 2+, (D) 783.90 2+, (E) 748.38 2+, (F) 698.85 2+, (G) 670.33 2+, (H) 596.80 2+; see 
Table 1). 
 
Figure 3. (A) Intensity of tryptic and semi-tryptic peptides from salivary α-amylase. 
Horizontal bars show mean. (B) Validation of selected proteolytic cleavage events in healthy 
subjects. Proportion of intensity of tryptic and semi-tryptic peptides corresponding to 
proteolysis at sequential positions between M323 and L329. Data points (,,,) 
represent different individuals. 
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Figure 3 
 
